We are live on ! Find out more
WSTAM

Wilbanks Smith & Thomas Asset Management Portfolio holdings

AUM $3.57B
1-Year Est. Return 21.11%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+21.11%
3 Year Est. Return
+25.24%
5 Year Est. Return
+75.04%
10 Year Est. Return
+189.02%
AUM
$841M
AUM Growth
+$92.4M
Cap. Flow
+$26.2M
Cap. Flow %
3.12%
Top 10 Hldgs %
42.06%
Holding
319
New
38
Increased
87
Reduced
115
Closed
28
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
126
Wells Fargo
WFC
$264B
$810K 0.1%
17,832
+172
+1% +$7.43K
BCR
127
DELISTED
CR Bard Inc.
BCR
$804K 0.1%
6,002
CSCO icon
128
Cisco
CSCO
$479B
$787K 0.09%
35,106
-8,013
-19% -$177K
RSPS icon
129
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$257M
$781K 0.09%
43,300
-5,235
-11% -$92.2K
ELV icon
130
Elevance Health
ELV
$85.5B
$763K 0.09%
8,260
+341
+4% +$30.3K
RAI
131
DELISTED
Reynolds American Inc
RAI
$747K 0.09%
29,874
AXP icon
132
American Express
AXP
$230B
$720K 0.09%
7,932
-67
-0.8% -$5.5K
HSY icon
133
Hershey
HSY
$36.6B
$708K 0.08%
7,279
+2
+0% +$192
AYI icon
134
Acuity Brands
AYI
$10.8B
$683K 0.08%
6,244
AMGN icon
135
Amgen
AMGN
$222B
$665K 0.08%
5,832
-63
-1% -$7.17K
VEA icon
136
Vanguard FTSE Developed Markets ETF
VEA
$236B
$665K 0.08%
15,955
+6,153
+63% +$250K
TXN icon
137
Texas Instruments
TXN
$261B
$657K 0.08%
14,954
-10,000
-40% -$419K
NOC icon
138
Northrop Grumman
NOC
$81.2B
$650K 0.08%
5,672
-525
-8% -$56.2K
IWO icon
139
iShares Russell 2000 Growth ETF
IWO
$15.1B
$647K 0.08%
4,777
+82
+2% +$10.6K
EGN
140
DELISTED
Energen
EGN
$640K 0.08%
9,048
-6
-0.1% -$451
IP icon
141
International Paper
IP
$22B
$635K 0.08%
13,862
SCHE icon
142
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$634K 0.08%
25,775
+1,665
+7% +$41.8K
GSK icon
143
GSK
GSK
$106B
$630K 0.07%
9,442
-1,079
-10% -$70K
DBEF icon
144
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$629K 0.07%
22,945
+15,020
+190% +$397K
CBRL icon
145
Cracker Barrel
CBRL
$1.29B
$627K 0.07%
5,692
WBA
146
DELISTED
Walgreens Boots Alliance
WBA
$615K 0.07%
10,707
+1
+0% +$58
UCC icon
147
ProShares Ultra Consumer Discretionary
UCC
$11.1M
$611K 0.07%
+63,240
New +$553K
IVE icon
148
iShares S&P 500 Value ETF
IVE
$49.8B
$599K 0.07%
7,008
-80
-1% -$6.59K
CURE icon
149
Direxion Daily Healthcare Bull 3X ETF
CURE
$182M
$596K 0.07%
43,085
-56,015
-57% -$701K
EFU icon
150
ProShares Trust UltraShort MSCI EAFE
EFU
$1.13M
$589K 0.07%
7,055
+1,220
+21% +$110K

Similar funds

Wilbanks Smith & Thomas Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Wilbanks Smith & Thomas Asset Management held 319 positions worth $841M, up 12% from $749M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Wilbanks Smith & Thomas Asset Management deployed $26.2M of net new capital in Q4 2013, opening 38 new positions and adding to 87 existing holdings. Its largest new stake was iPath S&P VEQTOR ETN: 67,354 shares worth $9.84M.

By sector, the portfolio is most concentrated in Industrials at 8.6% of assets, up from 8.5% a quarter earlier, followed by Consumer Staples and Energy.

On the sell side, the largest reduction was Invesco S&P 500 Top 50 ETF, an estimated $10.7M trimmed.

  • Wilbanks Smith & Thomas Asset Management's largest Q4 2013 buy was iPath S&P VEQTOR ETN: 67,354 shares worth $9.84M.
  • Wilbanks Smith & Thomas Asset Management added most to iShares MSCI EAFE Value ETF in Q4 2013, an estimated $13.5M increase.
  • Wilbanks Smith & Thomas Asset Management's biggest Q4 2013 reduction was Invesco S&P 500 Top 50 ETF, cutting an estimated $10.7M.
  • Wilbanks Smith & Thomas Asset Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $1.09M.
  • Wilbanks Smith & Thomas Asset Management's ten largest holdings make up 42% of its $841M portfolio in Q4 2013.
  • Wilbanks Smith & Thomas Asset Management opened 38 new positions and closed 28 in Q4 2013.
  • Wilbanks Smith & Thomas Asset Management's portfolio value rose 12% quarter-over-quarter to $841M.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2013, filed 28 Jan 2014.